InvestSMART

Mayne Pharma Group Limited (ASX:MYX)

ALERT: Price-sensitive ASX Announcement for MYX
Current share price for MYX : $2.830 0.29 (11.42%)+
Announcement
Release
6 Mar 2026 5:05PM
Price at Release
$2.540
Full Release
download
Summary
The document announces the quarterly rebalance of the S&P/ASX indices effective March 23, 2026. Mayne Pharma Group Limited, listed as MYX, was removed from the S&P/ASX 300 Index as part of these changes. The rebalance includes additions and removals across various indices such as S&P/ASX 20, 50, 100, and 200. Notably, Northern Star Resources Limited was added to the S&P/ASX 20 Index. These changes reflect the ongoing adjustments within the indices to ensure they accurately represent the Australian market landscape.
Key Points
  • S&P Dow Jones Indices announced changes to the S&P/ASX Indices for March 2026.
  • Mayne Pharma Group Limited (MYX) was removed from the S&P/ASX 300 Index.
  • Changes are effective prior to the open of trading on March 23, 2026.
  • The rebalance affects various indices including S&P/ASX 20, 50, 100, 200, and 300.
  • Northern Star Resources Limited was added to S&P/ASX 20 Index.
  • The S&P/ASX 300 Index saw numerous additions and removals of companies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.